342 related articles for article (PubMed ID: 28520642)
1. INFLAMMATORY CHOROIDAL NEOVASCULAR MEMBRANE: Long-Term Visual and Anatomical Outcomes After Intravitreal Anti-vascular Endothelial Growth Factor Therapy.
Dʼsouza P; Ranjan R; Babu U; Kanakath AV; Saravanan VR
Retina; 2018 Jul; 38(7):1307-1315. PubMed ID: 28520642
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization.
Rouvas A; Petrou P; Douvali M; Ntouraki A; Vergados I; Georgalas I; Markomichelakis N
Retina; 2011 May; 31(5):871-9. PubMed ID: 21358461
[TBL] [Abstract][Full Text] [Related]
3. Management of Choroidal Neovascular Membranes Associated with Choroidal Nevi.
Munie MT; Demirci H
Ophthalmol Retina; 2018 Jan; 2(1):53-58. PubMed ID: 31047303
[TBL] [Abstract][Full Text] [Related]
4. One-year outcomes of anti-vascular endothelial growth factor therapy in peripapillary choroidal neovascularisation.
Singh SR; Fung AT; Fraser-Bell S; Lupidi M; Mohan S; Gabrielle PH; Zur D; Iglicki M; M López-Corell P; Gallego-Pinazo R; Farinha C; Lima LH; Mansour AM; Casella AM; Wu L; Silva R; Uwaydat SH; Govindahari V; Arevalo JF; Chhablani J
Br J Ophthalmol; 2020 May; 104(5):678-683. PubMed ID: 31401554
[TBL] [Abstract][Full Text] [Related]
5. FIVE-YEAR OUTCOMES OF INTRAVITREAL INJECTION OF RANIBIZUMAB FOR THE TREATMENT OF MYOPIC CHOROIDAL NEOVASCULARIZATION.
Wu TT; Kung YH
Retina; 2017 Nov; 37(11):2056-2061. PubMed ID: 28590318
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory choroidal neovascularization in Indian eyes: Etiology, clinical features, and outcomes to anti-vascular endothelial growth factor.
Roy R; Saurabh K; Bansal A; Kumar A; Majumdar AK; Paul SS
Indian J Ophthalmol; 2017 Apr; 65(4):295-300. PubMed ID: 28513493
[TBL] [Abstract][Full Text] [Related]
7. FACTORS INFLUENCING VISUAL ACUITY IN PATIENTS RECEIVING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR MYOPIC CHOROIDAL NEOVASCULARIZATION.
Iacono P; Battaglia Parodi M; Selvi F; Parravano MC; Chiaravalloti A; Varano M; Bandello F
Retina; 2017 Oct; 37(10):1931-1941. PubMed ID: 28033235
[TBL] [Abstract][Full Text] [Related]
8. Reduced-fluence photodynamic therapy and anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy in an Indian population.
Sen P; Bhende M; Sachidanandam R; Bansal N; Sharma T
Indian J Ophthalmol; 2016 Dec; 64(12):908-913. PubMed ID: 28112132
[TBL] [Abstract][Full Text] [Related]
9. Three-year visual and anatomic results of administrating intravitreal bevacizumab in inflammatory ocular neovascularization.
Mansour AM; Arevalo JF; Fardeau C; Hrisomalos EN; Chan WM; Lai TY; Ziemssen F; Ness T; Sibai AM; Mackensen F; Wolf A; Hrisomalos N; Heiligenhaus A; Spital G; Jo Y; Gomi F; Ikuno Y; Akesbi J; LeHoang P; Adan A; Mahendradas P; Khairallah M; Guthoff R; Ghandour B; Küçükerdönmez C; Kurup SK
Can J Ophthalmol; 2012 Jun; 47(3):269-74. PubMed ID: 22687305
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal bevacizumab for inflammatory choroidal neovascularization: results from the Pan-American Collaborative Retina Study Group at 24 months.
Arevalo JF; Adan A; Berrocal MH; Espinoza JV; Maia M; Wu L; Roca JA; Quiroz-Mercado H; Ruiz-Moreno JM; Serrano MA;
Retina; 2011 Feb; 31(2):353-63. PubMed ID: 20890239
[TBL] [Abstract][Full Text] [Related]
11. CHOROIDAL THICKNESS AND CHORIORETINAL ATROPHY IN MYOPIC CHOROIDAL NEOVASCULARIZATION WITH ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY.
Lee JH; Lee SC; Kim SH; Koh HJ; Kim SS; Byeon SH; Lee CS
Retina; 2017 Aug; 37(8):1516-1522. PubMed ID: 27798519
[TBL] [Abstract][Full Text] [Related]
12. Clinical Outcomes of Eyes with Submacular Hemorrhage Secondary to Age-related Macular Degeneration Treated with Anti-vascular Endothelial Growth Factor.
Kim KH; Kim JH; Chang YS; Lee TG; Kim JW; Lew YJ
Korean J Ophthalmol; 2015 Oct; 29(5):315-24. PubMed ID: 26457037
[TBL] [Abstract][Full Text] [Related]
13. ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NAIVE IDIOPATHIC CHOROIDAL NEOVASCULARIZATION: A Comparative Study.
Sudhalkar A; Yogi R; Chhablani J
Retina; 2015 Jul; 35(7):1368-74. PubMed ID: 25830696
[TBL] [Abstract][Full Text] [Related]
14. Comparison of anatomical and visual outcomes following different anti-vascular endothelial growth factor treatments in subretinal neovascular membrane secondary to type 2 proliferative macular telangiectasia.
Karasu B; Gunay BO
Graefes Arch Clin Exp Ophthalmol; 2020 Jan; 258(1):99-106. PubMed ID: 31768680
[TBL] [Abstract][Full Text] [Related]
15. Choroidal neovascular membrane in paediatric patients: clinical characteristics and outcomes.
Padhi TR; Anderson BJ; Abbey AM; Yonekawa Y; Stem M; Alam D; Modi RR; Savla LP; Trese MT; Capone A; Drenser KA; Besirli CG
Br J Ophthalmol; 2018 Sep; 102(9):1232-1237. PubMed ID: 29217515
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Follow-Up of Choroidal Neovascularization due to Angioid Streaks with pro re nata Intravitreal Anti-VEGF Treatment.
Giacomelli G; Finocchio L; Biagini I; Sodi A; Murro V; Introini U; Varano M; Bandello F; Menchini U
Ophthalmologica; 2017; 238(1-2):44-51. PubMed ID: 28641290
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal bevacizumab in vascular pigment epithelium detachment as a result of subfoveal occult choroidal neovascularization in age-related macular degeneration.
Ach T; Hoeh AE; Ruppenstein M; Kretz FT; Dithmar S
Retina; 2010 Oct; 30(9):1420-5. PubMed ID: 20543764
[TBL] [Abstract][Full Text] [Related]
18. Long-term visual outcomes of intravitreal bevacizumab in inflammatory ocular neovascularization.
Mansour AM; Arevalo JF; Ziemssen F; Mehio-Sibai A; Mackensen F; Adan A; Chan WM; Ness T; Banker AS; Dodwell D; Chau Tran TH; Fardeau C; Lehoang P; Mahendradas P; Berrocal M; Tabbarah Z; Hrisomalos N; Hrisomalos F; Al-Salem K; Guthoff R
Am J Ophthalmol; 2009 Aug; 148(2):310-316.e2. PubMed ID: 19427992
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of Anti-vascular Endothelial Growth Factor Treatment for Foveal Serous Retinal Detachment Associated with Inferior Staphyloma.
Lee EK; Yu HG
Korean J Ophthalmol; 2019 Jun; 33(3):228-237. PubMed ID: 31179654
[TBL] [Abstract][Full Text] [Related]
20. Subfoveal choroidal thickness as a predictor of treatment response to anti-vascular endothelial growth factor therapy for polypoidal choroidal vasculopathy.
Kim H; Lee SC; Kwon KY; Lee JH; Koh HJ; Byeon SH; Kim SS; Kim M; Lee CS
Graefes Arch Clin Exp Ophthalmol; 2016 Aug; 254(8):1497-1503. PubMed ID: 26626772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
